Cargando…
RGD-expressed bacterial membrane-derived nanovesicles enhance cancer therapy via multiple tumorous targeting
Background: A tumor microenvironment is a complicated multicellular system comprised of tumor cells, immune cells and blood vessels. Blood vessels are the barriers for drug tissue penetration. Effectively treating a cancer requires drug delivery systems to overcome biological barriers present in tum...
Autores principales: | Gao, Jin, Wang, Sihan, Dong, Xinyue, Wang, Zhenjia |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Ivyspring International Publisher
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7847689/ https://www.ncbi.nlm.nih.gov/pubmed/33537088 http://dx.doi.org/10.7150/thno.51988 |
Ejemplares similares
-
Co-delivery of resolvin D1 and antibiotics with nanovesicles to lungs resolves inflammation and clears bacteria in mice
por: Gao, Jin, et al.
Publicado: (2020) -
Remote Co-loading of amphipathic acid drugs in neutrophil nanovesicles infilled with cholesterol mitigates lung bacterial infection and inflammation
por: Gao, Jin, et al.
Publicado: (2023) -
Dendritic Cell Membrane-Derived Nanovesicles for Targeted
T Cell Activation
por: Harvey, Brock T., et al.
Publicado: (2022) -
Bioinspired and biomimetic cancer-cell-derived membrane nanovesicles for preclinical tumor-targeted nanotheranostics
por: Prasad, Rajendra, et al.
Publicado: (2023) -
Mesenchymal stromal cell-derived nanovesicles ameliorate bacterial outer membrane vesicle-induced sepsis via IL-10
por: Park, Kyong-Su, et al.
Publicado: (2019)